Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06221852 · ClinicalTrials.gov registry record · NA
Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder
A NA study of Schizoaffective Disorder and Psychosis, sponsored by Mclean Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06221852 is a NA study of Schizoaffective Disorder and Psychosis that is actively recruiting participants, run by Mclean Hospital. The registered enrollment target is 50 participants, below the 201-participant average among 81 other Schizoaffective Disorder trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06221852, a NA study of Schizoaffective Disorder and Psychosis, is actively recruiting participants, sponsored by Mclean Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized, controlled clinical trial to assess the effects of the ketogenic diet in combination with treatment as usual on brain energy metabolism and psychiatric symptoms in individuals with first episode bipolar disorder and schizoaffective disorder.
Conditions Studied
Interventions
- OTHER Ketogenic diet
- OTHER Dietary Guidelines for Americans
Study Locations (1)
Massachusetts
- McLean Hospital - Belmont
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-03-12 |
| Est. Completion | 2027-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06221852
The ClinicalTrials.gov registry entry for NCT06221852 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 201-participant average among 81 other Schizoaffective Disorder trials with a reported enrollment target (75% lower). The listed sponsor is Mclean Hospital, which has 140 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Schizoaffective Disorder appearing as the primary indexed condition, and to 2 interventions - of which Ketogenic diet is the first listed.
NCT06221852 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06221852 about?
NCT06221852 is a clinical study titled "Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder". This is a randomized, controlled clinical trial to assess the effects of the ketogenic diet in combination with treatment as usual on brain energy metabolism and psychiatric symptoms in individuals with first episode bipolar disorder and schizoaffective disorder.
What is the current status of trial NCT06221852?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-03-12. Estimated completion is 2027-12-30.
What conditions does trial NCT06221852 study?
This clinical trial studies the following conditions: Schizoaffective Disorder, Psychosis, Bipolar I Disorder.
What interventions are being tested in trial NCT06221852?
The interventions under investigation include: Ketogenic diet (OTHER), Dietary Guidelines for Americans (OTHER).
Who is sponsoring clinical trial NCT06221852?
This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06221852 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizoaffective Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cerebellar Modulation of Cognition in Psychosis
RECRUITING · NA
-
Decision-Making in Schizophrenia: A Combined Neuroimaging and Experience Sampling Study
RECRUITING · NA
-
Effectiveness of Motivation Skills Training (MST)
RECRUITING · NA
-
Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode
RECRUITING · NA
-
Prebiotic Treatment in People With Schizophrenia
RECRUITING · NA
-
Reduction of Anticholinergic Medications Among Persons With Schizophrenia or Other Psychiatric Disorders
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.